ELECTROCOMPETENT CELLS MARKET ANALYSIS

Electrocompetent Cells Market, By Application (Cloning, Protein Expression, Mutagenesis, Genomic DNA Library Construction, Antibody Production, High-Throughput Screening, Others), By Cell Type (Escherichia coli (E. coli), Saccharomyces cerevisiae (S. cerevisiae), Bacillus subtilis (B. subtilis), Pseudomonas putida (P. putida), Streptococcus pneumoniae (S. pneumoniae), Others), By Transformation Efficiency (High Efficiency Cells, Ultra-High Efficiency Cells), By Packaging Format (Tubes, Plates, Custom Formats), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs), Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Oct 2023
Code : CMI5897
Pages :150
Formats :
Excel and PDF
Industry : Biotechnology

Leading Companies

Companies covered:

Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., QIAGEN N.V., New England Biolabs, Inc., GenScript Biotech Corporation, Lucigen Corporation, Takara Bio Inc., Delphi Genetics S.A., IBA GmbH, Scarab Genomics LLC, Zymo Research Corporation, Bioline GmbH (Meridian Bioscience), SelectScience, Biosearch Technology

Top companies in Electrocompetent Cells Market